【摘 要】
:
AIM: To observe the efficiency and safety of thymosin-α1treatment in patients with hepatitis B e antigen (HBeAg)and HBV DNA positive chronic hepatitis.METHODS:
【机 构】
:
Epidemiology Unit,Department of Infectious Diseases,Department of Hepatopathy,Department of Internal